TRERF1 and immune system disorder: Particularly, rapa delivery through both microparticle and nanoparticle formulations in vivo has shown significant immune engineering promise across multiple species models in the study of chronic inflammation, transplant rejection, and auto-immune disorders (Fan et al., 2019; Fisher et al., 2019; Nguyen et al., 2022).